Propofol versus midazolam: Safety and efficacy for sedating the severe trauma patient

Anesthesia and Analgesia

Volumn 86, Issue 6, 1998, Pages 1219-1224

  Sanchez Izquierdo Riera, Jose A ^a,b   Caballero Cubedo, Rafael E ^a   Perez Vela, Jose L ^a   Ambros Checa, Alfonso ^a   Cantalapiedra Santiago, Jose A ^a   Alted Lopez, Emilio ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PROPOFOL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODYNAMICS; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEDATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANALGESICS, OPIOID; ANESTHESIA RECOVERY PERIOD; BLOOD PRESSURE; BRAIN; CRANIOCEREBRAL TRAUMA; DRUG COMBINATIONS; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPNOTICS AND SEDATIVES; INCIDENCE; INFUSIONS, INTRAVENOUS; INTRACRANIAL PRESSURE; JUGULAR VEINS; MALE; MIDAZOLAM; MORPHINE; OXYGEN; PROPOFOL; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SAFETY; TRIGLYCERIDES; WOUNDS AND INJURIES;

EID: 0031839352     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199806000-00016     Document Type: Article

References (25)

1. Roumen RM, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-80.
2. Cinat M, Waxman K, Vaziri ND, et al. Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma 1995;39:112-20.
3. Baker CC, Faist E. Immunologic response. In: Moore EE, Mattox KL, Feliciano DV, eds. Trauma. Norwalk, CT: Appleton and Lange, 1991:881-90.
4. Bruder N, Lessegue D, Pelissier D, et al. Energy expenditure and withdrawal of sedation in severe head-injured patients. Crit Care Med 1994;22:1114-9.
5. Wheeler AP. Sedation, analgesia and paralysis in the intensive care unit. Chest 1993;104:566-77.
6. Crippen DW. The role of sedation in the ICU patient with pain and agitation. Crit Care Clin 1990;6:369-92.
7. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA 1991;266:2870-5.
8. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology 1985;62:310-24.
9. Malacrida R, Fritz ME, Suter PM, Crevoisier CH. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1991;20: 1123-6.
10. Oldenhof H, Jong M, Steenhock A, Janknegt RR. Clinical pharmacokinetics of midazolam in intensive care patients: a wide interpatient variability? Clin Pharmacol Ther 1988;43:263-9.
11. Byatt CM, Lewis LD, Dawling S, Cochrane GM. Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. BMJ 1984;289: 799-800.
12. Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;50:636-57.
13. Newman LH, McDonald JC, Wallace PGM, et al. Propofol infusion for sedation in intensive care. Anaesthesia 1987;42:929-37.
14. Carrasco G, Molina R, Costa J, et al. Propofol vs midazolam in short, medium, and long-term sedation of critically ill patients: a cost-benefit analysis. Chest 1993;103:557-64.
15. Marmarou A, Anderson RL, Ward JD, et al. NINDS Traumatic Coma Data Bank: intracranial pressure monitoring methodology. J Neurosurg 1991;75:21-7.
16. Ramsay M, Savege T, Simpson B, et al. Controlled sedation with alphaxolone-alphadolona. BMJ 1974;2:656-9.
17. Hansen-Flaschen J, Cowen J, Palomano RC. Beyond the Ramsay scale: need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med 1994;22:732-3.
18. Wang DY. Assessment of the sedation in ICU. Intensive Care World 1993;10:193-6.
19. Barrientos-Vega R, Sánchez-Soria MM, Morales-Garcia C, et al. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997;25: 33-40.
20. Chamorro C, De Latorre F, Montero A, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients. Crit Care Med 1996;24:932-9.
21. Aitkenhead AR, Pepperman ML, Willatts SH, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989;2:704-9.
22. Ronan KP, Gallagher TJ, George B, Hamby B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med 1995;23:286-93.
23. Farling PA, Johnston JR, Coppel DL. Propofol infusion compared with morphine and midazolam bolus doses for sedation of patients with severe head injuries in the intensive care unit. J Drug Dev 1989;2(Suppl 2):97-8.
24. Cook S, Palma O. Propofol as a sole agent for prolonged infusion in intensive care. J Drug Dev 1989;2(Suppl 2):65-8.
25. Gottardis M, Khünl-Brady KS, Koller W, et al. Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 1989;62:393-6.